Cognitive Impairment

DENVER — Cognitive impairment in Parkinson’s is a mitigating factor for presence of blood-based biomarkers during sleep as indicator of disease progression, according to a poster at the American Academy of Neurology annual meeting.

March is Multiple Sclerosis Awareness Month, a time to improve knowledge of and highlight the growing treatment options for progressive types of this degenerative disease.

WEST PALM BEACH, Fla. — Variability and length of pauses in speech may indicate cognitive impairment for German-speaking individuals with multiple sclerosis, according to a poster from ACTRIMS 2024.

Kidney disease-related cognitive impairment, such as episodic and verbal declarative memory, may improve after transplantation, researchers found in a longitudinal study.

Two blood-based biomarkers may help identify patients with cancer who are more likely to experience gastrointestinal symptoms during chemotherapy.

Peritoneal dialysis is largely underused on a global scale, according to a scenario-based survey that explored the preconceptions of kidney care physicians as a barrier to access.

Researchers reported that a population-based study shows statin use among older adults with heart failure was associated with a 20% lower risk for all-cause dementia, including a 28% reduction in risk for developing Alzheimer’s disease.

Physical activity was only minimally associated with a reduced risk for cognitive decline or impairment. Even so, the finding was still significant from a population health perspective, according to researchers.

Data from a survey conducted in the Netherlands show most cardiologists do not routinely screen for cognitive impairment in older patients with HF, but they were open to the idea of a dedicated “heart-brain clinic” to give such full care.

A plasma phosphorylated-tau217 assay demonstrated a high degree of accuracy in identifying biomarkers consistent with Alzheimer’s disease-related pathology, according to research from JAMA Neurology.